Co-Diagnostics vs Sintx Technologies
CODX and SINT side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CODX and SINT compare
Sintx Technologies is the larger company, worth 6.2 times as much as Co-Diagnostics ($10.8M against $1.7M).
Sintx Technologies grew revenue faster over the last twelve months (161% versus 69.1% for Co-Diagnostics).
Sintx Technologies keeps more of each dollar of sales as profit, with a net margin of −282% compared with −5528% at Co-Diagnostics.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CODX | SINT |
|---|---|---|
| Size and price | ||
| Market cap | $1.7M | $10.8M |
| Share price | $0.278 | $1.62 |
| Change, 1 year | −97.6% | −54.5% |
| Change, 5 years | −99.9% | −100.0% |
| Beta (5Y) | 1.76 | 1.59 |
| Employees | 115 | 32 |
| StockData Score | ||
| Total score | 6 | 6 |
| Valuation score | 1 | 1 |
| Growth score | 1 | 2 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 4 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 2.0× (better) | 3.3× |
| P/B | 0.2× (better) | 3.2× |
| FCF yield | −1565% | −85.7% (better) |
| Fair value | – | $1.22 |
| Margin of safety | – | −32.5% |
| Growth | ||
| Revenue growth (TTM) | 69.1% | 161% (better) |
| Revenue growth, 5Y average | −61.6% | 11.4% (better) |
| Profitability | ||
| Gross margin | 20.3% | 59.5% (better) |
| Operating margin | −5614% | −303% (better) |
| Net margin | −5528% | −282% (better) |
| FCF margin | −3166% | −279% (better) |
| Return on equity | −195% (better) | −250% |
| Return on invested capital | −208% | – |
| Financial health | ||
| Debt / equity | 0.00 | 0.02 (better) |
| Current ratio | 0.77 | 1.84 (better) |
| Altman Z-score | −23.29 (better) | −48.89 |
| Piotroski F-score | 1 | 2 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 9.5% | 14.5% |
| Held by insiders | 14.7% | 4.2% |
| Insider net buying, 12 months | – | $326K |
| Short interest, % of float | 18.4% | 2.0% |
Go deeper
- CODX stock overview
- CODX income statement
- CODX valuation and score
- SINT stock overview
- SINT income statement
- SINT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.